Product Information
RIFAMPIN 300 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.6891 per EA under NDC 60687058601. Its NADAC has been published 269 times since May 5, 2021.
Strength
300 mg/1
Manufacturer
American Health PackagingNDC
60687058601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIFAMPINApproval Type
Generic (ANDA)
FDA Application
ANDA090034On Market Since
3/9/2021
Pharmacological Classes
Price Statistics
The NADAC for RIFAMPIN 300 MG CAPSULE has been published 269 times since May 5, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6891 per EA |
|---|---|
| All-time high | $0.9590 (Apr 13, 2022) |
| All-time low | $0.4888 (Nov 20, 2024) |
| 52-week high | $0.7246 |
| 52-week low | $0.6805 |
| Median price | $0.6935 |
| Average price | $0.6898 |
| Largest weekly change | -29.8% (Apr 20, 2022) |
| Weeks tracked | 269 |
| Tracking since | May 5, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Rifampin market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of RIFAMPIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIFAMPIN 300 MG CAPSULE, manufactured by American Health Packaging, is $0.6891 per EA (NDC 60687058601), effective Jun 24, 2026.
How has the price of RIFAMPIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIFAMPIN 300 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 269 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for RIFAMPIN 300 MG CAPSULE?
Since May 5, 2021, the NADAC for RIFAMPIN 300 MG CAPSULE has ranged from a low of $0.4888 (Nov 20, 2024) to a high of $0.9590 (Apr 13, 2022), with a median of $0.6935 per EA.
Are there cheaper alternatives to RIFAMPIN 300 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RIFAMPIN 300 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures RIFAMPIN 300 MG CAPSULE?
RIFAMPIN 300 MG CAPSULE (NDC 60687058601) is labeled by American Health Packaging, and CMS classifies it as a generic product.
Related Drugs
Same classification